Clinical trial involving Mente system begins in US

15 June, 2016

An independent clinical trial titled, Neurofeedback therapy for children diagnosed with autism, has commenced in the United States.

The trial is being conducted by Carrick Institute for Graduate Studies, has two aims:

• to further explore the effectiveness of a novel sonified Neurofeedback management therapy for children diagnosed with Autism Spectrum Disorder (ASD), and

• to determine if balance control is different before and after therapy.

This interventional clinical trial is independent, randomised and double blind.

The investigators in the trial are: Frederick R. Carrick (primary), Elena Oggero, Guido Pagnacco, Ahmed Hankir, Rashid Zaman and Robert Thatcher.

Full details of the study can be found here. is a service of the US National Institutes of Health.